Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations

Addiction Biology

Volumn 19, Issue 2, 2014, Pages 145-155

  Calipari, Erin S ^a   Ferris, Mark J ^a   Melchior, James R ^a   Bermejo, Kristel ^b   Salahpour, Ali ^b   Roberts, David C S ^a   Jones, Sara R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cocaine; dopamine; dopamine transporter; methylphenidate; nucleus accumbens; self administration

Indexed keywords

CENTRAL STIMULANT AGENT; COCAINE; DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; METHYLPHENIDATE; TYROSINE 3 MONOOXYGENASE;

ANIMAL; DRUG EFFECTS; DRUG SELF ADMINISTRATION; ELECTROCHEMICAL ANALYSIS; MALE; METABOLISM; NUCLEUS ACCUMBENS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROCEDURES; RAT; REINFORCEMENT; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ELECTROCHEMICAL TECHNIQUES; MALE; METHYLPHENIDATE; NUCLEUS ACCUMBENS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; TYROSINE 3-MONOOXYGENASE;

EID: 84894465769     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2012.00456.x     Document Type: Article

References (51)

1. Ahmed SH, Koob GF, (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282: 298-300.
2. Barrett SP, Darredeau C, Bordy LE, Pihl RO, (2005) Characteristics of methylphenidate misuse in a university student sample. Can J Psychiatry 50: 457-461.
3. Biederman J, Spencer T, (2002) Methylphenidate in treatment of adults with attention-deficit/hyperactivity disorder. J Atten Disord 6: S101-S107.
4. Botly LC, Burton CL, Rizos Z, Fletcher PJ, (2008) Characterization of methylphenidate self-administration and reinstatement in the rat. Psychopharmacology (Berl) 199: 55-66.
5. Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F, (2003) The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can J Psychiatry 48: 546-554.
6. Burton CL, Nobrega JN, Fletcher PJ, (2010) The effects of adolescent methylphenidate self-administration on responding for a conditioned reward, amphetamine-induced locomotor activity, and neuronal activation. Psychopharmacology (Berl) 208: 455-468.
7. Cadet JL, McCoy MT, Cai NS, Krasnova IN, Ladenheim B, Beauvais G, Wilson N, Wood W, Becker KG, Hodges AB, (2009) Methamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatum. PLoS ONE 12: e7812.
8. Chen R, Han DD, Gu HH, (2005) A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate. J Neurochem 94: 352-359.
9. Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, Ching S, Quan N, Stephens RL, Hill ER, Nottoli T, Han DD, Gu HH, (2006) Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci U S A 103: 9333-9338.
10. Dar DE, Mayo C, Uhl GR, (2005) The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands. Biochem Pharmacol 70: 461-469.
11. Di Chiara G, Imperato A, (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85: 5274-5278.
12. Ferris MJ, Calipari ES, Mateo Y, Melchior JR, Roberts DC, Jones SR, (in press) Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate. Neuropsychopharmacology.
13. Ferris MJ, Mateo Y, Roberts DC, Jones SR, (2011) Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration. Biol Psychiatry 69: 201-207.
14. Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D, Molina PE, Dewey SL, (2000) Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J Pharmacol Exp Ther 295: 51-57.
15. Han DD, Gu HH, (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 3: 6.
16. Heal DJ, Cheetham SC, Smith SL, (2009) The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 57: 608-618.
17. Heal DJ, Prow MR, Hearson M, Buckett WR, (1996) Efflux of [3H]dopamine from superfused rat striatal slices: predictive value for detecting stimulant drugs of abuse. Br J Pharmacol 117: 325P.
18. Hu YF, Caron MG, Sieber-Blum M, (2009) Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis. BMC Genomics 10: 151.
19. Huff JK, Davies MI, (2002) Microdialysis monitoring of methylphenidate in blood and brain correlated with changes in dopamine and rat activity. J Pharm Biomed Anal 29: 767-777.
20. Hurd YL, Weiss F, Koob GF, And NE, Ungerstedt U, (1989) Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. Brain Res 498: 199-203.
21. Li SM, Campbell BL, Katz JL, (2006) Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine. J Pharmacol Exp Ther 317: 1088-1096.
22. Marusich JA, Bardo MT, (2009) Differences in impulsivity on a delay-discounting task predict self-administration of a low unit dose of methylphenidate in rats. Behav Pharmacol 20: 447-454.
23. Marusich JA, Beckmann JS, Gipson CD, Bardo MT, (2010) Methylphenidate as a reinforcer for rats: contingent delivery and intake escalation. Exp Clin Psychopharmacol 18: 257-266.
24. Mateo Y, Lack CM, Morgan D, Roberts DC, Jones SR, (2005) Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharm 30: 1455-1463.
25. Morton WA, Stockton GG, (2000) Methylphenidate abuse and psychiatric side effects. Prim Care Companion J Clin Psychiatry 2: 159-164.
26. Norman AB, Tsibulsky VL, (2006) The compulsion zone: a pharmacological theory of acquired cocaine self-administration. Brain Res 1116: 143-152.
27. Ramamoorthy S, Samuvel DJ, Balasubramaniam A, See RE, Jayanthi LD, (2010) Altered dopamine transporter function and phosphorylation following chronic cocaine self-administration and extinction in rats. Biochem Biophys Res Commun 391: 1517-1521.
28. Richardson NR, Roberts DC, (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1-11.
29. Roberts DC, Goeders NE, (1989) Drug self-administration: experimental methods and determiants. In:, Boalton AA, Baker GB, Greenshaw AS, eds. Neuromethods, Vol. 13. Psychopharmacology, pp. 349-398. Clifton, NJ: Humana press.
30. Roberts DC, Morgan D, Liu Y, (2007) How to make a rat addicted to cocaine. Prog Neuropsychopharmacol Biol Psychiatry 31: 1614-1624.
31. Rush CR, Baker RW, (2001) Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol 9: 59-73.
32. Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J, (1998) Differences between electrically-, ritalin- and d-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 94: 163-171.
33. Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E, Ghisi V, Nicholls PJ, Wong L, Murphy K, Sesack SR, Wightman RM, Gainetdinov RR, Caron MG, (2008) Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci USA 105: 4405-4410.
34. Sherman CB, Hudson LD, Pierson DJ, (1987) Severe precocious emphysema in intravenous methylphenidate (Ritalin) abusers. Chest 92: 1085-1087.
35. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG, (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17: 960-974.
36. Sproson EJ, Chantrey J, Hollis C, Marsden CA, Fonel KC, (2001) Effect of repeated methylphenidate administration on presynaptic dopamine and behaviour in young adult rats. J Psychopharmacol 15: 67-75.
37. Substance Abuse and Mental Health Services Administration (SAMHSA) (2008) National Survey on Drug Use and Health. Retrieved at http://www.oas.samhsa.gov/ nhsda.htm. Accessed 15 May 2010.
38. Tank AW, Xu L, Chen X, Radcliffe P, Sterling CR, (2008) Post-transcriptional regulation of tyrosine hydroxylase expression in adrenal medulla and brain. Ann N Y Acad Sci 1148: 238-248.
39. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ, (2006) Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 26: 1501-1510.
40. Tilley MR, Gu HH, (2008a) The effects of methylphenidate on knockin mice with a methylphenidate-resistant dopamine transporter. J Pharmacol Exp Ther 327: 554-560.
41. Tilley MR, Gu HH, (2008b) Dopamine transporter inhibition is required for cocaine-induced stereotypy. Neuroreport 19: 1137-1140.
42. Uhl GR, Hall FS, Sora I, (2002) Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7: 21-26.
43. Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ, (2002) Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord 6 (Suppl 1): S31-S43.
44. Volz TJ, Farnsworth SJ, Hanson GR, Fleckenstein AE, (2008) Methylphenidate-induced alterations in synaptic vesicle trafficking and activity. Ann N Y Acad Sci 1139: 285-290.
45. Wayment HK, Deutsch H, Schweri MM, Schenk JO, (1999) Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists? J Neurochem 72: 1266-1274.
46. Weikop P, Egestad B, Kehr J, (2004) Application of triple-probe microdialysis for fast pharmacokinetic/pharmacodynamic evaluation of dopamimetic activity of drug candidates in the rat brain. J Neurosci Methods 140: 59-65.
47. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S, (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 47: 21-31.
48. Wilson JM, Kish SJ, (1996) The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. J Neurosci 16: 3507-3510.
49. Woods SK, Meyer JS, (1991) Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine in the nucleus accumbens: a microdialysis study. Brain Res 560: 97-105.
50. Yang PB, Swann AC, Dafny N, (2003) Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. Life Sci 73: 2899-2911.
51. Yorgason JT, España RA, Jones SR, (2011) Demon Voltammetry and Analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202: 158-164.